Jana Sampad, Iram Shabina, Thomas Joice, Liekens Sandra, Dehaen Wim
Molecular Design and Synthesis, Department of Chemistry, KU Leuven, Celestijnenlaan 200F, 3001 Leuven, Belgium.
Department of Plant Biotechnology, Atta-Ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), H-12 Islamabad, Pakistan.
Bioorg Med Chem. 2017 Jul 15;25(14):3671-3676. doi: 10.1016/j.bmc.2017.04.041. Epub 2017 Apr 30.
Three series of aza-artemisinin derivatives were synthesized for studies of anticancer activity. The first series of compounds were prepared via copper(I)-catalyzed azide alkyne cycloaddition, so called "click reaction", starting from propargyl derivatives of 11-aza-artemisinin and various azides, whereas the second and third series of compounds were prepared by triazolization reaction starting from enolizable ketones and primary amines connected to artemisinin. In vitro studies of the 23 synthesized artemisinin derivatives unveiled that 9 compounds displayed antiproliferative activity in the low micromolar range, with 5d being the most promising compound showing 50% inhibition of Cem and HeLa cell growth at 0.92 and 1.2µM, respectively.
合成了三系列氮杂青蒿素衍生物用于抗癌活性研究。第一系列化合物通过铜(I)催化的叠氮化物-炔烃环加成反应(即所谓的“点击反应”)制备,从11-氮杂青蒿素的炔丙基衍生物和各种叠氮化物开始;而第二和第三系列化合物通过从可烯醇化的酮和与青蒿素相连的伯胺开始的三唑化反应制备。对23种合成的青蒿素衍生物的体外研究表明,9种化合物在低微摩尔范围内显示出抗增殖活性,其中5d是最有前景的化合物,分别在0.92和1.2µM时对Cem和HeLa细胞生长有50%的抑制作用。